-
Adalimumab serum concentration to choose a subsequent biological DMARD in patients with rheumatoid arthritis (ADDORA-switch): results of a blinded randomised test-treatment trial
Wientjes, M. H. M., Atiqi, S., Wolbink, G. J., Nurmohamed, M. T., Boers, M., Hooijberg, F., Rispens, T., de Vries, A., van Vollenhoven, R. F., Ramiro, S., van Herwaarden, N., van den Bemt, B. J. F. & den Broeder, A. A., Aug 2025, In: Annals of the rheumatic diseases. 84, 8, p. 1293-1300 8 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology
Besten, Y. R., Boekel, L., Steenhuis, M., Hooijberg, F., Atiqi, S., Leeuw, M., Vogelzang, E. H., Keijser, J., Keijzer, S., Loeff, F. C., Gerritsen, M., Tas, S. W., Nurmohamed, M. T., Rispens, T. & Wolbink, G., 19 Apr 2024, In: RMD open. 10, 2, e003933.Research output: Contribution to journal › Article* › Academic › peer-review
-
Changes in Tumor Necrosis Factor Inhibitor Drug Survival in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis Over 15 Years
Visman, I. M., Atiqi, S., Boers, M., Twisk, J. W. R. & Nurmohamed, M. T., 2024, In: Journal of rheumatology. 51, 1, p. 84-87 4 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
